ClinicalTrials.gov record
Completed Phase 2 Interventional

Pleconaril Enteroviral Sepsis Syndrome

ClinicalTrials.gov ID: NCT00031512

Public ClinicalTrials.gov record NCT00031512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Virologic Efficacy Trial of Pleconaril in the Treatment of Neonates With Enteroviral Sepsis Syndrome

Study identification

NCT ID
NCT00031512
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
61 participants

Conditions and interventions

Interventions

  • Placebo Other
  • Pleconaril Drug

Other · Drug

Eligibility (public fields only)

Age range
0 Days to 15 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2001
Primary completion
Sep 21, 2010
Completion
Sep 14, 2012
Last update posted
Feb 4, 2024

2001 – 2012

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
Children's of Alabama Child Health Research Unit (CHRU) Birmingham Alabama 35233-0011
University of Arkansas - Arkansas Children's Hospital Research Institute Little Rock Arkansas 72202-3500
Ronald Reagan University of California Los Angeles Medical Center Los Angeles California 90095-8358
Rady Children's Hospital San Diego San Diego California 92123-4223
Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases Stanford California 94305-2200
Children's Hospital Colorado - Infectious Disease Aurora Colorado 80045-7106
University of Florida - Shands Children's Hospital Gainesville Florida 32610-0296
The University of Chicago - Comer Children's Hospital - Infectious Diseases Chicago Illinois 60637-1425
University of Louisville School of Medicine - Norton Children's Hospital - Infectious Diseases Louisville Kentucky 40202-1821
Tulane University - Tulane Medical Center - Pediatrics New Orleans Louisiana 70112-2600
University of Mississippi - Children's Infectious Diseases Jackson Mississippi 39216-4505
Washington University School of Medicine in St. Louis - Center for Clinical Studies St Louis Missouri 63110-1010
University of Nebraska Medical Center - Children's Hospital and Medical Center - Infectious Diseases Omaha Nebraska 68114-4108
Childrens Hospital at Saint Peters University Hospital - Allergy, Immunology and Infectious Diseases New Brunswick New Jersey 08901-1766
SUNY Upstate Medical University Hospital - Pediatrics Syracuse New York 13210-2342
Nationwide Children's Hospital - Infectious Diseases Columbus Ohio 43205-2664
Children's Hospital of Pittsburgh of UPMC - Allergy, Immunology and Infectious Diseases Pittsburgh Pennsylvania 15213-3320
Rhode Island Hospital - Pediatrics Providence Rhode Island 02903-4923
Vanderbilt University - Pediatric - Infectious Diseases Nashville Tennessee 37232-0011
Parkland Memorial Hospital Dallas Texas 75235-7708
University of Texas Southwestern Medical Center - Pediatrics Dallas Texas 75390-9063
Cook Children's Infectious Disease Services Fort Worth Texas 76104-2710
University of Texas Medical Branch - Pediatrics - Infectious Diseases and Immunology - Galveston Galveston Texas 77555-5302
University of Texas Health Science Center San Antonio - Pediatrics - Immunology & Infectious Disease San Antonio Texas 78229-3901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00031512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2024 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00031512 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →